Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2010 1
2011 1
2012 1
2013 2
2014 5
2015 6
2016 1
2017 5
2018 3
2019 4
2020 12
2021 15
2022 9
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Results by year

Filters applied: . Clear all
Page 1
PET/CT in Multiple Myeloma: Beyond FDG.
Matteucci F, Paganelli G, Martinelli G, Cerchione C. Matteucci F, et al. Front Oncol. 2021 Jan 25;10:622501. doi: 10.3389/fonc.2020.622501. eCollection 2020. Front Oncol. 2021. PMID: 33569348 Free PMC article. Review.
Is It Time to Introduce PET/CT in Rectal Cancer Guidelines?
Maffione AM, Montesi G, Caroli P, Colletti PM, Rubello D, Matteucci F. Maffione AM, et al. Among authors: matteucci f. Clin Nucl Med. 2020 Aug;45(8):611-617. doi: 10.1097/RLU.0000000000003132. Clin Nucl Med. 2020. PMID: 32558716 Review.
Radioligand therapies in cancer: mapping the educational landscape in Europe.
Bugani V, Battistelli L, Sansovini M, Monti M, Paganelli G, Gich I, Flotats A, Erba PA, Blay JY, la Fougère C, Van Poppel H, Charalambous A, Herrmann K, Giordano A, Györke T, Deroose C, Matteucci F, Carrió I. Bugani V, et al. Among authors: matteucci f. Eur J Nucl Med Mol Imaging. 2023 Jul;50(9):2692-2698. doi: 10.1007/s00259-023-06217-0. Epub 2023 Apr 14. Eur J Nucl Med Mol Imaging. 2023. PMID: 37058168 Free PMC article.
Targeted radioactive therapy for prostate cancer.
De Giorgi U, Conteduca V, Gurioli G, Matteucci F, Paganelli G. De Giorgi U, et al. Among authors: matteucci f. Lancet. 2021 Aug 7;398(10299):487-488. doi: 10.1016/S0140-6736(21)01336-2. Lancet. 2021. PMID: 34364517 No abstract available.
ITA-IMMUNO-PET: The Role of [18F]FDG PET/CT for Assessing Response to Immunotherapy in Patients with Some Solid Tumors.
Evangelista L, Bianchi A, Annovazzi A, Sciuto R, Di Traglia S, Bauckneht M, Lanfranchi F, Morbelli S, Nappi AG, Ferrari C, Rubini G, Panareo S, Urso L, Bartolomei M, D'Arienzo D, Valente T, Rossetti V, Caroli P, Matteucci F, Aricò D, Bombaci M, Caponnetto D, Bertagna F, Albano D, Dondi F, Gusella S, Spimpolo A, Carriere C, Balma M, Buschiazzo A, Gallicchio R, Storto G, Ruffini L, Cervati V, Ledda RE, Cervino AR, Cuppari L, Burei M, Trifirò G, Brugola E, Zanini CA, Alessi A, Fuoco V, Seregni E, Deandreis D, Liberini V, Moreci AM, Ialuna S, Pulizzi S, De Rimini ML. Evangelista L, et al. Among authors: matteucci f. Cancers (Basel). 2023 Jan 31;15(3):878. doi: 10.3390/cancers15030878. Cancers (Basel). 2023. PMID: 36765835 Free PMC article.
Flare phenomenon in prostate cancer: recent evidence on new drugs and next generation imaging.
Conteduca V, Poti G, Caroli P, Russi S, Brighi N, Lolli C, Schepisi G, Romeo A, Matteucci F, Paganelli G, Marchetti P, De Giorgi U. Conteduca V, et al. Among authors: matteucci f. Ther Adv Med Oncol. 2021 Feb 24;13:1758835920987654. doi: 10.1177/1758835920987654. eCollection 2021. Ther Adv Med Oncol. 2021. PMID: 33708265 Free PMC article. Review.
Importance of PET with 68Ga-Labeled Somatostatin Analogs.
Paganelli G, Matteucci F. Paganelli G, et al. Among authors: matteucci f. J Nucl Med. 2020 Dec;61(Suppl 2):187S-188S. doi: 10.2967/jnumed.120.254631. J Nucl Med. 2020. PMID: 33293439 Free article. No abstract available.
Diagnostic effectiveness of [18F]Fluoroestradiol PET/CT in oestrogen receptor-positive breast cancer: the key role of histopathology. Evidence from an international multicentre prospective study.
Bottoni G, Fiz F, Puntoni M, Matteucci F, Monti M, DeCensi A, Nanni O, Brain E, Alberini JL, Dib B, Sacchetti G, Trimboli P, Treglia G, Harbeck N, Sola S, Gennari A, Piccardo A. Bottoni G, et al. Among authors: matteucci f. Eur J Nucl Med Mol Imaging. 2023 Jul;50(8):2477-2485. doi: 10.1007/s00259-023-06173-9. Epub 2023 Mar 7. Eur J Nucl Med Mol Imaging. 2023. PMID: 36879065
Can Baseline [18F]FDG PET/CT Predict Response to Immunotherapy After 6 Months and Overall Survival in Patients with Lung Cancer or Malignant Melanoma? A Multicenter Retrospective Study.
Bianchi A, De Rimini ML, Sciuto R, Annovazzi A, Di Traglia S, Bauckneht M, Lanfranchi F, Morbelli S, Nappi AG, Ferrari C, Rubini G, Panareo S, Urso L, Bartolomei M, D'Arienzo D, Valente T, Rossetti V, Caroli P, Matteucci F, Aricò D, Bombaci M, Caponnetto D, Bertagna F, Albano D, Dondi F, Gusella S, Spimpolo A, Carriere C, Balma M, Buschiazzo A, Gallicchio R, Storto G, Ruffini L, Scarlattei M, Baldari G, Cervino AR, Cuppari L, Burei M, Trifirò G, Brugola E, Zanini CA, Alessi A, Fuoco V, Seregni E, Deandreis D, Liberini V, Moreci AM, Ialuna S, Pulizzi S, Evangelista L. Bianchi A, et al. Among authors: matteucci f. Cancer Biother Radiopharm. 2023 May;38(4):256-267. doi: 10.1089/cbr.2022.0092. Epub 2023 Apr 25. Cancer Biother Radiopharm. 2023. PMID: 37098169
61 results